Discontinuation report AZITHROMYCIN FOR INJECTION, USP

Last updated on 2018-02-15 History
Report ID 15804
Drug Identification Number 02385473
Brand name AZITHROMYCIN FOR INJECTION, USP
Common or Proper name AZITHROMYCIN FOR INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10VL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-07-12
Remaining supply date 2017-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply There is no saleable inventory remaining.
Company comments Last Lot # 7602631 and Expires 31-Jul-17
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-02-15 French Compare
v7 2018-02-15 English Compare
v6 2017-07-17 French Compare
v5 2017-07-17 English Compare
v4 2017-07-17 French Compare
v3 2017-07-17 English Compare
v2 2017-07-17 English Compare
v1 2017-07-17 English Compare

Showing 1 to 8 of 8